<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02539264</url>
  </required_header>
  <id_info>
    <org_study_id>DEES-OSA</org_study_id>
    <nct_id>NCT02539264</nct_id>
  </id_info>
  <brief_title>Impact of Smoking, Benzodiazepine (BZD) Use and Obesity on Severe Obstructive Sleep Apnea (sOSA)</brief_title>
  <official_title>Impact of Smoking, BZD and Obesity on Severe Obstructive Sleep Apnea (sOSA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Astes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Astes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators will analyze the influence of smoking, benzodizepine use, and
      obesity among patients with severe Obstructive Sleep Apnea (sOSA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a retrospective study. Patients enrolled: all patients with a PSG
      (polysomnography) between 1st January 2014 and 30th June 2015.

      First analysis: influence of smoking, benzodiazepine use, and obesity on the AHI (Apnea
      Hypopnea Index: the number of apnea and hypopnea per hour of sleep).

      Second analysis: only among patients with sOSA: influence of smoking, benzodiazepine use, and
      obesity on sleep fragmentation and night oximetry.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea Hypopnea Index</measure>
    <time_frame>1 day</time_frame>
    <description>Apnea Hypopnea Index (AHI) is defined as the number of apnea and hypopnea per hour of sleep. It is the major determinant of the severity of OSA.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep fragmentation defined by the percentage of time spent in each of the four stades of sleep (Stade 1, Stade 2, Slow wave sleep and Rapid Eye Movements)</measure>
    <time_frame>1 day</time_frame>
    <description>Are smoking and/or obesity a risk factor for sleep fragmentation?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent under 90% of SpO2 during the night</measure>
    <time_frame>1 day</time_frame>
    <description>Are smoking and/or obesity a risk factor for oxygen desaturation (&lt; 90% SpO2) during the night?</description>
  </secondary_outcome>
  <enrollment type="Actual">920</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Obesity</condition>
  <condition>Smoking</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Smoking</intervention_name>
    <description>Influence of smoking on parameters derived from overnight PSG</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Obesity</intervention_name>
    <description>Influence of obesity on parameters derived from overnight PSG</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Benzodiazepine use</intervention_name>
    <description>Influence of benzodiazepine use on parameters derived from overnight PSG</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients registered for an overnight PSG at Clinique Saint-Luc of Bouge
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients registered for an overnight PSG at Clinique Saint-Luc of Bouge

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric DEFLANDRE, MD, FCCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Astes</affiliation>
  </overall_official>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2015</study_first_submitted>
  <study_first_submitted_qc>September 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2015</study_first_posted>
  <last_update_submitted>January 5, 2016</last_update_submitted>
  <last_update_submitted_qc>January 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Astes</investigator_affiliation>
    <investigator_full_name>Eric DEFLANDRE, MD, FCCP</investigator_full_name>
    <investigator_title>MD, FCCP</investigator_title>
  </responsible_party>
  <keyword>All patients registered for A PSG</keyword>
  <keyword>polysomnography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

